Market Tracker

04/26 2:57pm ET

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

113.30
Delayed Data
As of 2:42pm ET
 +4.39 / +4.03%
Today’s Change
13.09
Today|||52-Week Range
154.75
+23.43%
Year-to-Date
No recent news for Madrigal Pharmaceuticals Inc.

Today’s Trading

Previous close108.91
Today’s open109.29
Day’s range107.62 - 116.45
Volume184,774
Average volume (3 months)254,557
Market cap$2.0B
Data as of 2:42pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)+72.67%
Earnings growth (this year)+48.62%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book45.55

Competitors

 Today’s
change
Today’s
% change
OVIDOvid Therapeutics In...+0.34+3.51%
STMLStemline Therapeutic...+0.80+4.71%
ZYMEZymeworks Inc+1.30+9.89%
NEOSNeos Therapeutics In...+0.17+2.11%
Data as of 2:57pm ET, 04/26/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$0.00
Annual profit (last year)-$26.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Paul A. Friedman
Chief Financial Officer &
Senior Vice President
Marc R. Schneebaum
Corporate headquarters
Fort Washington, Pennsylvania

Forecasts